Siemens reviews majority stake in Healthineers as CFO cites insufficient synergies

reuters.com

Siemens AG is reviewing its majority stake in Siemens Healthineers, worth about 45 billion euros. CFO Ralf Thomas stated that the synergies with the medical technology subsidiary are insufficient to justify this investment. Previously, Siemens had committed to retaining its 75% stake since spinning off Healthineers in 2018. However, Thomas indicated a potential sale of around 5% to help finance the acquisition of U.S. software company Altair. Thomas reaffirmed Siemens' commitment to its Mobility division, dismissing calls for its spin-off. He stated that the division is well-managed and there is no current need to divest.


With a significance score of 3.8, this news ranks in the top 5.2% of today's 29389 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Siemens reviews majority stake in Healthineers as CFO cites insufficient synergies | News Minimalist